As a global supplier and partner within drug discovery and clinical diagnostics, Svar Life Science has nearly 30 years of experience serving the life science market with diagnostic laboratory services aimed at helping customers move forward in the drug development process and ensuring optimal treatment of patients by providing accurate assay solutions for the clinical diagnostic laboratory.
Our strong Scandinavian roots are embodied in a high-quality, responsive, people- and solution-focused business. Through mergers, acquisitions, in-house innovation, industry collaboration and knowledge exchange, we continue to find and harness the optimal solutions for improved patient care and accelerated drug development.
In 2018 Euro Diagnostica changed its name to Svar Life Science. Our new name, which means answers in Swedish, reflects our values and Scandinavian heritage, and positions us for doing business in life science.
In 2017 the Norwegian company Calpro AS became part of the Svar Life Science group. Calpro AS was founded by the inventors of the technology behind the ELISA kits for determination of calprotectin in stools and other biological materials. Today, the company is one of the major suppliers of diagnostic tools based around the calprotectin protein.
In 2014 we acquired Danish life science company Biomonitor A/S adding the iLite® technology and cell-based reporter gene assays to the product portfolio. This addition enabled us to expand our offering to encompass the entire drug development value chain.
This included sales of iLite to biopharma and CROs, establishment of patient monitoring through lab developed tests in the US, and the building of a dedicated bioanalytical services unit.